Interventional Not yet recruiting
NCT05326165 on ClinicalTrials.gov
Early Intervention
Official title: Preventing the Progression of Low Volume Swelling to Breast Cancer-related Lymphedema: a Pilot Study
- Sponsor: Massachusetts General Hospital
- Collaborators: Heinz Family Foundation, Adele McKinnon Research Fund for Breast Cancer-Related Lymphedema, Olayan-Xefos Family Fund for Breast Cancer Research
- Enrollment: 40 (Estimated)
- Study start: 2027-05-01 (Estimated)
- Primary completion: 2027-06-30 (Estimated)
- Study completion: 2027-06-30 (Estimated)
- Allocation: N/a
- InterventionModel: Single Group
- Masking: None
- PrimaryPurpose: Supportive Care
Brief Summary
This research study is a Pilot Study examining the use of a compression sleeve with embedded sensor to prevent lymphedema.
Conditions
- Breast Cancer
- Breast Cancer Treatment Related Lymphedema
Intervention / Treatment
- Device: Juzo Compression Sleeve and Glove
- Device: Compression Sleeve Sensor
Primary Outcome Measures
-
Arm Volume
(1, 3, 6, 9 and 12 months)
Primary objective is efficacy of compression intervention to change rate of progression from low volume swelling (LVS) (relative volume change (RVC) 5-\<10%) to breast cancer-related lymphedema (BCRL) (RVC \>/=10%). Measurement of effect of the compression intervention will be completed with arm volume measurements using perometry (infrared optical electronic scanner) .
Countries
United States
Locations and Investigators
-
Massachusetts General Hospital Cancer Center, Boston, United States
- Alphonse G Taghian, MD PhD
- Alphonse G Taghian, MD PhD (Principal Investigator)
Study Officials
- Alphonse G Taghian, MD, PhD (Principal Investigator) — Massachusetts General Hospital